Sarepta Therapeutics (SRPT): Q4 EPS of -$2.36 may not be comparable to consensus of $-0.27....

|About: Sarepta Therapeutics, Inc. (SRPT)|By:, SA News Editor
Sarepta Therapeutics (SRPT): Q4 EPS of -$2.36 may not be comparable to consensus of $-0.27. Revenue of $7.3M beats by $0.6M.